Kentucky Childrens Hospital Location: 800 Rose Street, Mn-109, Lexington, Kentucky, 40536 Rating: Not Available Phone: (859) 323-8965 |
DCI - Lexington Chain: Dialysis Clinic, Inc. Location: 100 Venture Court, Lexington, Kentucky, 40511 Rating: Phone: (859) 252-7712 |
DCI - South Lexington Chain: Dialysis Clinic, Inc. Location: 2374 Professional Heights Dr., Lexington, Kentucky, 40503 Rating: Phone: (859) 967-0400 |
Fmc- Lexington South Dialysis Chain: Fresenius Medical Care Location: 171 N Eagle Creek Dr Ste 110, Lexington, Kentucky, 40509 Rating: Phone: (859) 264-7775 |
FMC - Kentucky Renal Care Group - Lexington East Chain: Fresenius Medical Care Location: 1101 Winchester Rd., Suite 100, Lexington, Kentucky, 40505 Rating: Phone: (859) 225-4922 |
FMC - Lexington North Chain: Fresenius Medical Care Location: 1610 Leestown Rd., Suite 180, Lexington, Kentucky, 40511 Rating: Phone: (859) 254-0671 |
FMC - Nalco Home Program Chain: Fresenius Medical Care Location: 1591 Winchester Rd., Ste 102, Lexington, Kentucky, 40505 Rating: Not Available Phone: (859) 299-3379 |
Davita - Hamburg Dialysis Chain: Davita Location: 1745 Alysheba Way, Suite 110, Lexington, Kentucky, 40509 Rating: Phone: (859) 543-0084 |
Davita - Kentucky Home Training Chain: Davita Location: 2130 Nicholasville Road, Suite 5, Lexington, Kentucky, 40503 Rating: Not Available Phone: (859) 277-9911 |
Fmc- Lexington Southwest Chain: Fresenius Medical Care Location: 978 Chas Drive, Lexington, Kentucky, 40515 Rating: Not Available Phone: (859) 260-1706 |
News Archive
Subgroups of tuberculosis (TB)-causing bacteria can persist even when antibiotics wipe out most of the overall population. The need to eliminate these persistent subpopulations is one reason why TB treatment regimens are so lengthy.
BioCryst Pharmaceuticals, Inc. announced preliminary top-line results from its multinational, open-label, single-arm trial evaluating 200 mg once-daily oral forodesine in the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL), as well as interim results from the Company's exploratory Phase 2 study to investigate the efficacy and safety of 200 mg twice-daily oral forodesine as monotherapy for chronic lymphocytic leukemia (CLL).
As you read this article, touch receptors in your skin are sensing your environment. Your clothes and jewelry, the chair you're sitting on, the computer keyboard or mobile device you're using, even your fingers as they brush one another unintentionally-;each touch activates collections of nerve cells.
An Ohio State University molecular biologist leveraged a supercomputer to help better define the family tree of a group of enzymes that have been implicated in a wide range of human diseases and are important targets for anti-cancer therapies.
› Verified 5 days ago
Dialysis is used as a temporary measure in either acute kidney injury or in those awaiting kidney transplant and as a permanent measure in those for whom a transplant is not indicated or not possible. Dialysis facility in medicare covers outpatient maintenance dialysis treatments, training for self-dialysis, self-dialysis support services and self-dialysis equipment and supplies. In some cases, Medicare may cover ambulance transportation when the patient has End-Stage Renal Disease (ESRD), need dialysis, and need ambulance transportation to or from a dialysis facility.
The star rating shows how well a dialysis center delivers care compared to the national average, based on Medicare data. Each dialysis center receives a rating between 1 and 5 stars, with 3 stars representing the national average. A five-star rating means a center has quality of care that is considered 'much above average' compared to other dialysis facilities. A one or two-star rating means that measured health outcomes for that center were below average. The star rating is part of Medicare's work to make data on the quality of patient care easier to understand and use. Patient survey results aren't included in the star rating.